{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:37:57Z","timestamp":1790689077018,"version":"4.1.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"23","license":[{"start":{"date-parts":[[2018,3,16]],"date-time":"2018-03-16T00:00:00Z","timestamp":1521158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1038\/s41388-018-0209-0","type":"journal-article","created":{"date-parts":[[2018,3,14]],"date-time":"2018-03-14T10:49:47Z","timestamp":1521024587000},"page":"3166-3182","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":128,"title":["Collagen abundance controls melanoma phenotypes through lineage-specific microenvironment sensing"],"prefix":"10.1038","volume":"37","author":[{"given":"Zsofia","family":"Miskolczi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily J.","family":"Rowling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Barriuso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3825-6381","authenticated-orcid":false,"given":"Claudia","family":"Wellbrock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,16]]},"reference":[{"key":"209_CR1","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1111\/j.1600-0749.2006.00322.x","volume":"19","author":"KS Hoek","year":"2006","unstructured":"Hoek KS, Schlegel NC, Brafford P, Sucker A, Ugurel S, Kumar R, et al. Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature. Pigment Cell Res. 2006;19:290\u2013302.","journal-title":"Pigment Cell Res"},{"key":"209_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14343","volume":"8","author":"IS Kim","year":"2017","unstructured":"Kim IS, Heilmann S, Kansler ER, Zhang Y, Zimmer M, Ratnakumar K, et al. Microenvironment-derived factors driving metastatic plasticity in melanoma. Nat Commun. 2017;8:14343.","journal-title":"Nat Commun"},{"key":"209_CR3","doi-asserted-by":"publisher","first-page":"7969","DOI":"10.1158\/0008-5472.CAN-09-0781","volume":"69","author":"S Pinner","year":"2009","unstructured":"Pinner S, Jordan P, Sharrock K, Bazley L, Collinson L, Marais R, et al. Intravital imaging reveals transient changes in pigment production and Brn2 expression during metastatic melanoma dissemination. Cancer Res. 2009;69:7969\u201377.","journal-title":"Cancer Res"},{"key":"209_CR4","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1158\/1535-7163.MCT-16-0535","volume":"16","author":"A Ahn","year":"2017","unstructured":"Ahn A, Chatterjee A, Eccles MR. The slow cycling phenotype: a growing problem for treatment resistance in melanoma. Mol Cancer Ther. 2017;16:1002\u20139.","journal-title":"Mol Cancer Ther"},{"key":"209_CR5","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1111\/febs.14040","volume":"284","author":"I Arozarena","year":"2017","unstructured":"Arozarena I, Wellbrock C. Targeting invasive properties of melanoma cells. FEBS J. 2017;284:2148\u201362.","journal-title":"FEBS J"},{"key":"209_CR6","doi-asserted-by":"publisher","first-page":"352","DOI":"10.3389\/fonc.2014.00352","volume":"4","author":"N Vandamme","year":"2014","unstructured":"Vandamme N, Berx G. Melanoma cells revive an embryonic transcriptional network to dictate phenotypic heterogeneity. Front Oncol. 2014;4:352.","journal-title":"Front Oncol"},{"key":"209_CR7","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1111\/j.1600-0625.2011.01314.x","volume":"20","author":"K Frey","year":"2011","unstructured":"Frey K, Fiechter M, Schwager K, Belloni B, Barysch MJ, Neri D, et al. Different patterns of fibronectin and tenascin-C splice variants expression in primary and metastatic melanoma lesions. Exp Dermatol. 2011;20:685\u20138.","journal-title":"Exp Dermatol"},{"key":"209_CR8","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.tcb.2010.08.015","volume":"21","author":"H Yu","year":"2011","unstructured":"Yu H, Mouw JK, Weaver VM. Forcing form and function: biomechanical regulation of tumor evolution. Trends Cell Biol. 2011;21:47\u201356.","journal-title":"Trends Cell Biol"},{"key":"209_CR9","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.semcancer.2015.09.001","volume":"35","author":"A Nagelkerke","year":"2015","unstructured":"Nagelkerke A, Bussink J, Rowan AE, Span PN. The mechanical microenvironment in cancer: How physics affects tumours. Semin Cancer Biol. 2015;35:62\u201370.","journal-title":"Semin Cancer Biol"},{"key":"209_CR10","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.mcna.2017.03.005","volume":"101","author":"CI Lee","year":"2017","unstructured":"Lee CI, Chen LE, Elmore JG. Risk-based breast cancer screening: implications of breast density. Med Clin N Am. 2017;101:725\u201341.","journal-title":"Med Clin N Am"},{"key":"209_CR11","doi-asserted-by":"publisher","first-page":"6555","DOI":"10.1021\/acs.biochem.5b01014","volume":"54","author":"K Zhang","year":"2015","unstructured":"Zhang K, Qi HX, Hu ZM, Chang YN, Shi ZM, Han XH, et al. YAP and TAZ take center stage in cancer. Biochemistry. 2015;54:6555\u201366.","journal-title":"Biochemistry"},{"key":"209_CR12","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1152\/physrev.00005.2014","volume":"94","author":"S Piccolo","year":"2014","unstructured":"Piccolo S, Dupont S, Cordenonsi M. The biology of YAP\/TAZ: hippo signaling and beyond. Physiol Rev. 2014;94:1287\u2013312.","journal-title":"Physiol Rev"},{"key":"209_CR13","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1007\/s00018-016-2412-x","volume":"74","author":"MH Kim","year":"2017","unstructured":"Kim MH, Kim J. Role of YAP\/TAZ transcriptional regulators in resistance to anti-cancer therapies. Cell Mol Life Sci. 2017;74:1457\u201374.","journal-title":"Cell Mol Life Sci"},{"key":"209_CR14","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/ng.3218","volume":"47","author":"L Lin","year":"2015","unstructured":"Lin L, Sabnis AJ, Chan E, Olivas V, Cade L, Pazarentzos E, et al. The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies. Nat Genet. 2015;47:250\u20136.","journal-title":"Nat Genet"},{"key":"209_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7683","volume":"6","author":"A Verfaillie","year":"2015","unstructured":"Verfaillie A, Imrichova H, Atak ZK, Dewaele M, Rambow F, Hulselmans G, et al. Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. Nat Commun. 2015;6:6683.","journal-title":"Nat Commun"},{"key":"209_CR16","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/jid.2013.319","volume":"134","author":"F Nallet-Staub","year":"2014","unstructured":"Nallet-Staub F, Marsaud V, Li L, Gilbert C, Dodier S, Bataille V, et al. Pro-invasive activity of the Hippo pathway effectors YAP and TAZ in cutaneous melanoma. J Invest Dermatol. 2014;134:123\u201332.","journal-title":"J Invest Dermatol"},{"key":"209_CR17","doi-asserted-by":"publisher","first-page":"167025","DOI":"10.1155\/2015\/167025","volume":"2015","author":"M Akhmanova","year":"2015","unstructured":"Akhmanova M, Osidak E, Domogatsky S, Rodin S. Domogatskaya A. Physical, spatial, and molecular aspects of extracellular matrix of in vivo niches and artificial scaffolds relevant to stem cells research. Stem Cells Int. 2015;2015:167025.","journal-title":"Stem Cells Int"},{"key":"209_CR18","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1126\/science.1171643","volume":"324","author":"DE Discher","year":"2009","unstructured":"Discher DE, Mooney DJ, Zandstra PW. Growth factors, matrices, and forces combine and control stem cells. Science. 2009;324:1673\u20137.","journal-title":"Science"},{"key":"209_CR19","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nature10137","volume":"474","author":"S Dupont","year":"2011","unstructured":"Dupont S, Morsut L, Aragona M, Enzo E, Giulitti S, Cordenonsi M, et al. Role of YAP\/TAZ in mechanotransduction. Nature. 2011;474:179\u201383.","journal-title":"Nature"},{"key":"209_CR20","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1242\/dev.133728","volume":"143","author":"A Elbediwy","year":"2016","unstructured":"Elbediwy A, Vincent-Mistiaen ZI, Spencer-Dene B, Stone RK, Boeing S, Wculek SK, et al. Integrin signalling regulates YAP and TAZ to control skin homeostasis. Development. 2016;143:1674\u201387.","journal-title":"Development"},{"key":"209_CR21","doi-asserted-by":"publisher","first-page":"9770","DOI":"10.1364\/OE.14.009770","volume":"14","author":"SJ Kirkpatrick","year":"2006","unstructured":"Kirkpatrick SJ, Wang RK, Duncan DD, Kulesz-Martin M, Lee K. Imaging the mechanical stiffness of skin lesions by in vivo acousto-optical elastography. Opt Express. 2006;14:9770\u20139.","journal-title":"Opt Express"},{"key":"209_CR22","doi-asserted-by":"publisher","first-page":"2962","DOI":"10.1242\/dev.125807","volume":"142","author":"LJ Manderfield","year":"2015","unstructured":"Manderfield LJ, Aghajanian H, Engleka KA, Lim LY, Liu F, Jain R, et al. Hippo signaling is required for Notch-dependent smooth muscle differentiation of neural crest. Development. 2015;142:2962\u201371.","journal-title":"Development"},{"key":"209_CR23","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1111\/pcmr.12370","volume":"28","author":"C Wellbrock","year":"2015","unstructured":"Wellbrock C, Arozarena I. Microphthalmia-associated transcription factor in melanoma development and MAP-kinase pathway targeted therapy. Pigment Cell Melanoma Res. 2015;28:390\u2013406.","journal-title":"Pigment Cell Melanoma Res"},{"key":"209_CR24","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.ccell.2016.02.003","volume":"29","author":"MP Smith","year":"2016","unstructured":"Smith MP, Brunton H, Rowling EJ, Ferguson J, Arozarena I, Miskolczi Z, et al. Inhibiting drivers of non-mutational drug tolerance is a salvage strategy for targeted melanoma therapy. Cancer Cell. 2016;29:270\u201384.","journal-title":"Cancer Cell."},{"key":"209_CR25","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1101\/gad.1602907","volume":"21","author":"B Zhao","year":"2007","unstructured":"Zhao B, Wei X, Li W, Udan RS, Yang Q, Kim J, et al. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev. 2007;21:2747\u201361.","journal-title":"Genes Dev"},{"key":"209_CR26","doi-asserted-by":"publisher","first-page":"e2734","DOI":"10.1371\/journal.pone.0002734","volume":"3","author":"C Wellbrock","year":"2008","unstructured":"Wellbrock C, Rana S, Paterson H, Pickersgill H, Brummelkamp T, Marais R. Oncogenic BRAF regulates melanoma proliferation through the lineage specific factor MITF. PLoS ONE. 2008;3:e2734.","journal-title":"PLoS ONE."},{"key":"209_CR27","doi-asserted-by":"publisher","first-page":"3356","DOI":"10.1158\/1078-0432.CCR-09-2509","volume":"16","author":"G Jonsson","year":"2010","unstructured":"Jonsson G, Busch C, Knappskog S, Geisler J, Miletic H, Ringner M, et al. Gene expression profiling-based identification of molecular subtypes in stage IV melanomas with different clinical outcome. Clin Cancer Res. 2010;16:3356\u201367.","journal-title":"Clin Cancer Res"},{"key":"209_CR28","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.celrep.2014.06.045","volume":"8","author":"A Chapman","year":"2014","unstructured":"Chapman A, Fernandez del Ama L, Ferguson J, Kamarashev J, Wellbrock C, Hurlstone A. Heterogeneous tumor subpopulations cooperate to drive invasion. Cell Rep. 2014;8:688\u201395.","journal-title":"Cell Rep"},{"key":"209_CR29","doi-asserted-by":"publisher","first-page":"717","DOI":"10.7150\/jca.10865","volume":"6","author":"L Zhou","year":"2015","unstructured":"Zhou L, Yang K, Andl T, Wickett RR, Zhang Y. Perspective of targeting cancer-associated fibroblasts in melanoma. J Cancer. 2015;6:717\u201326.","journal-title":"J Cancer"},{"key":"209_CR30","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.stem.2009.12.010","volume":"6","author":"EK Nishimura","year":"2010","unstructured":"Nishimura EK, Suzuki M, Igras V, Du J, Lonning S, Miyachi Y, et al. Key roles for transforming growth factor beta in melanocyte stem cell maintenance. Cell Stem Cell. 2010;6:130\u201340.","journal-title":"Cell Stem Cell"},{"key":"209_CR31","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/jnci\/djs471","volume":"105","author":"MP Smith","year":"2013","unstructured":"Smith MP, Ferguson J, Arozarena I, Hayward R, Marais R, Chapman A, et al. Effect of SMURF2 targeting on susceptibility to MEK inhibitors in melanoma. J Natl Cancer Inst. 2013;105:33\u201346.","journal-title":"J Natl Cancer Inst"},{"key":"209_CR32","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.molcel.2008.11.002","volume":"32","author":"G Yang","year":"2008","unstructured":"Yang G, Li Y, Nishimura EK, Xin H, Zhou A, Guo Y, et al. Inhibition of PAX3 by TGF-beta modulates melanocyte viability. Mol Cell. 2008;32:554\u201363.","journal-title":"Mol Cell"},{"key":"209_CR33","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1084\/jem.20111653","volume":"209","author":"M Fujii","year":"2012","unstructured":"Fujii M, Toyoda T, Nakanishi H, Yatabe Y, Sato A, Matsudaira Y, et al. TGF-beta synergizes with defects in the Hippo pathway to stimulate human malignant mesothelioma growth. J Exp Med. 2012;209:479\u201394.","journal-title":"J Exp Med"},{"key":"209_CR34","doi-asserted-by":"publisher","first-page":"13461","DOI":"10.1074\/jbc.M113.529115","volume":"289","author":"SE Hiemer","year":"2014","unstructured":"Hiemer SE, Szymaniak AD, Varelas X. The transcriptional regulators TAZ and YAP direct transforming growth factor beta-induced tumorigenic phenotypes in breast cancer cells. J Biol Chem. 2014;289:13461\u201374.","journal-title":"J Biol Chem"},{"key":"209_CR35","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.devcel.2014.06.003","volume":"30","author":"JE Mahoney","year":"2014","unstructured":"Mahoney JE, Mori M, Szymaniak AD, Varelas X, Cardoso WV. The hippo pathway effector Yap controls patterning and differentiation of airway epithelial progenitors. Dev Cell. 2014;30:137\u201350.","journal-title":"Dev Cell"},{"key":"209_CR36","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1016\/j.cell.2015.05.044","volume":"161","author":"Cancer Genome Atlas N.","year":"2015","unstructured":"Cancer Genome Atlas N. Genomic classification of cutaneous melanoma. Cell. 2015;161:1681\u201396.","journal-title":"Cell"},{"key":"209_CR37","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.cell.2009.10.027","volume":"139","author":"KR Levental","year":"2009","unstructured":"Levental KR, Yu H, Kass L, Lakins JN, Egeblad M, Erler JT, et al. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell. 2009;139:891\u2013906.","journal-title":"Cell"},{"key":"209_CR38","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.ad.2012.10.003","volume":"104","author":"I Bielsa Marsol","year":"2013","unstructured":"Bielsa Marsol I. Update on the classification and treatment of localized scleroderma. Actas Dermosifiliogr. 2013;104:654\u201366.","journal-title":"Actas Dermosifiliogr"},{"key":"209_CR39","doi-asserted-by":"publisher","first-page":"403","DOI":"10.4103\/0970-0358.101328","volume":"45","author":"S Chadwick","year":"2012","unstructured":"Chadwick S, Heath R, Shah M. Abnormal pigmentation within cutaneous scars: a complication of wound healing. Indian J Plast Surg. 2012;45:403\u201311.","journal-title":"Indian J Plast Surg"},{"key":"209_CR40","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1002\/jcb.21204","volume":"101","author":"JT Lee","year":"2007","unstructured":"Lee JT, Herlyn M. Microenvironmental influences in melanoma progression. J Cell Biochem. 2007;101:862\u201372. PubMed PMID: 17171636","journal-title":"J Cell Biochem"},{"key":"209_CR41","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1021\/mp200421k","volume":"8","author":"EH Flach","year":"2011","unstructured":"Flach EH, Rebecca VW, Herlyn M, Smalley KS, Anderson AR. Fibroblasts contribute to melanoma tumor growth and drug resistance. Mol Pharm. 2011;8:2039\u201349.","journal-title":"Mol Pharm"},{"key":"209_CR42","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1084\/jem.20160855","volume":"214","author":"HL Young","year":"2017","unstructured":"Young HL, Rowling EJ, Bugatti M, Giurisato E, Luheshi N, Arozarena I, et al. An adaptive signaling network in melanoma inflammatory niches confers tolerance to MAPK signaling inhibition. J Exp Med. 2017;214:1691\u2013710.","journal-title":"J Exp Med"},{"key":"209_CR43","doi-asserted-by":"publisher","first-page":"E2441","DOI":"10.1073\/pnas.1212021109","volume":"109","author":"JM Lamar","year":"2012","unstructured":"Lamar JM, Stern P, Liu H, Schindler JW, Jiang ZG, Hynes RO. The Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domain. Proc Natl Acad Sci USA. 2012;109:E2441\u201350.","journal-title":"Proc Natl Acad Sci USA"},{"key":"209_CR44","doi-asserted-by":"publisher","first-page":"3579","DOI":"10.1242\/dev.064014","volume":"138","author":"KL Taylor","year":"2011","unstructured":"Taylor KL, Lister JA, Zeng Z, Ishizaki H, Anderson C, Kelsh RN, et al. Differentiated melanocyte cell division occurs in vivo and is promoted by mutations in Mitf. Development. 2011;138:3579\u201389.","journal-title":"Development"},{"key":"209_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-11366-y","volume":"7","author":"JL Simmons","year":"2017","unstructured":"Simmons JL, Pierce CJ, Al-Ejeh F, Boyle GM. MITF and BRN2 contribute to metastatic growth after dissemination of melanoma. Sci Rep. 2017;7:10909.","journal-title":"Sci Rep"},{"key":"209_CR46","doi-asserted-by":"crossref","first-page":"17844","DOI":"10.18632\/oncotarget.7528","volume":"7","author":"AA Brozyna","year":"2016","unstructured":"Brozyna AA, Jozwicki W, Roszkowski K, Filipiak J, Slominski AT. Melanin content in melanoma metastases affects the outcome of radiotherapy. Oncotarget. 2016;7:17844\u201353.","journal-title":"Oncotarget"},{"key":"209_CR47","doi-asserted-by":"publisher","first-page":"12297","DOI":"10.18632\/oncotarget.3655","volume":"6","author":"H Cirenajwis","year":"2015","unstructured":"Cirenajwis H, Ekedahl H, Lauss M, Harbst K, Carneiro A, Enoksson J, et al. Molecular stratification of metastatic melanoma using gene expression profiling: prediction of survival outcome and benefit from molecular targeted therapy. Oncotarget. 2015;6:12297\u2013309.","journal-title":"Oncotarget"},{"key":"209_CR48","doi-asserted-by":"publisher","first-page":"11683","DOI":"10.18632\/oncotarget.3549","volume":"6","author":"J Nsengimana","year":"2015","unstructured":"Nsengimana J, Laye J, Filia A, Walker C, Jewell R, Van den Oord JJ, et al. Independe1nt replication of a melanoma subtype gene signature and evaluation of its prognostic value and biological correlates in a population cohort. Oncotarget. 2015;6:11683\u201393.","journal-title":"Oncotarget"},{"key":"209_CR49","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.15252\/emmm.201607156","volume":"9","author":"MP Smith","year":"2017","unstructured":"Smith MP, Rowling EJ, Miskolczi Z, Ferguson J, Spoerri L, Haass NK, et al. Targeting endothelin receptor signalling overcomes heterogeneity driven therapy failure. EMBO Mol Med. 2017;9:1011\u201329.","journal-title":"EMBO Mol Med"},{"key":"209_CR50","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1083\/jcb.201502040","volume":"210","author":"NR Paul","year":"2015","unstructured":"Paul NR, Allen JL, Chapman A, Morlan-Mairal M, Zindy E, Jacquemet G, et al. alpha5beta1 integrin recycling promotes Arp2\/3-independent cancer cell invasion via the formin FHOD3. J Cell Biol. 2015;210:1013\u201331.","journal-title":"J Cell Biol"},{"key":"209_CR51","doi-asserted-by":"publisher","first-page":"3513","DOI":"10.1046\/j.1432-1327.2000.01378.x","volume":"267","author":"C Wellbrock","year":"2000","unstructured":"Wellbrock C, Schartl M. Activation of phosphatidylinositol 3-kinase by a complex of p59fyn and the receptor tyrosine kinase Xmrk is involved in malignant transformation of pigment cells. Eur J Biochem. 2000;267:3513\u201322.","journal-title":"Eur J Biochem"},{"key":"209_CR52","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1038\/sj.onc.1201693","volume":"16","author":"N Dimitrijevic","year":"1998","unstructured":"Dimitrijevic N, Winkler C, Wellbrock C, Gomez A, Duschl J, Altschmied J, et al. Activation of the Xmrk proto-oncogene of Xiphophorus by overexpression and mutational alterations. Oncogene. 1998;16:1681\u201390.","journal-title":"Oncogene"},{"key":"209_CR53","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1046\/j.1432-1327.1999.00180.x","volume":"260","author":"C Wellbrock","year":"1999","unstructured":"Wellbrock C, Schartl M. Multiple binding sites in the growth factor receptor Xmrk mediate binding to p59fyn, GRB2 and Shc. Eur J Biochem. 1999;260:275\u201383.","journal-title":"Eur J Biochem"},{"key":"209_CR54","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1158\/2159-8290.CD-13-1007","volume":"4","author":"MP Smith","year":"2014","unstructured":"Smith MP, Sanchez-Laorden B, O\u2019Brien K, Brunton H, Ferguson J, Young H, et al. The immune microenvironment confers resistance to MAPK pathway inhibitors through macrophage-derived TNFalpha. Cancer Discov. 2014;4:1214\u201329.","journal-title":"Cancer Discov"},{"key":"209_CR55","doi-asserted-by":"publisher","first-page":"W147","DOI":"10.1093\/nar\/gkw419","volume":"44","author":"S Babicki","year":"2016","unstructured":"Babicki S, Arndt D, Marcu A, Liang Y, Grant JR, Maciejewski A, et al. Heatmapper: web-enabled heat mapping for all. Nucleic Acids Res. 2016;44:W147\u201353.","journal-title":"Nucleic Acids Res"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41388-018-0209-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41388-018-0209-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41388-018-0209-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T17:10:53Z","timestamp":1684602653000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-018-0209-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,16]]},"references-count":55,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["209"],"URL":"https:\/\/doi.org\/10.1038\/s41388-018-0209-0","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,16]]},"assertion":[{"value":"27 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}